Delving into the Latest Updates on Jiangsu Zhengrui Medical Technology Co., Ltd. with Synapse

Overview

评价江苏征瑞医药科技有限公司生产的硝呋太尔制霉菌素阴道软胶囊（规格：每粒含硝呋太尔0.5g和制霉菌素200,000单位）与普利化学工业公司、意大利多帕药业有限公司生产的对照药品硝呋太尔制霉菌素阴道软胶囊麦咪康帕®（规格：每粒含硝呋太尔0.5g和制霉菌素200,000单位）的有效性是否有差异，评价两制剂是否为等效性制剂。

[Translation]

To evaluate whether there is any difference in effectiveness between the nifuratel-nystatin vaginal soft capsules (specification: each capsule contains 0.5 g nifuratel and 200,000 units of nystatin) produced by Jiangsu Zhengrui Pharmaceutical Technology Co., Ltd. and the control drug nifuratel-nystatin vaginal soft capsules Mamicompa® (specification: each capsule contains 0.5 g nifuratel and 200,000 units of nystatin) produced by Pulli Chemical Industry Company and Dopa Pharmaceutical Co., Ltd. of Italy, and to evaluate whether the two preparations are equivalent preparations.

Start Date11 Sep 2023

Sponsor / Collaborator

Jiangsu Zhengrui Medical Technology Co., Ltd.

100 Clinical Results associated with Jiangsu Zhengrui Medical Technology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Jiangsu Zhengrui Medical Technology Co., Ltd.

Login to view more data

100 Deals associated with Jiangsu Zhengrui Medical Technology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Jiangsu Zhengrui Medical Technology Co., Ltd.

Login to view more data